DBOL — Dhampur Bio Organics Balance Sheet
0.000.00%
- IN₹5.17bn
- IN₹16.40bn
- IN₹26.93bn
- 39
- 74
- 36
- 49
Annual balance sheet for Dhampur Bio Organics, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | PROSPECTUS | PROSPECTUS | ARS | ARS | ARS |
| Standards: | IAS | IAS | IAS | IAS | IAS |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 139 | 230 | 1,045 | 305 | 333 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 1,124 | 1,099 | 1,800 | 1,213 | 822 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 9,006 | 12,220 | 11,249 | 12,516 | 12,290 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 6,377 | 7,684 | 9,455 | 10,494 | 11,551 |
| Net Goodwill | |||||
| Long Term Investments | |||||
| Long Term Notes Receivable | |||||
| Other Long Term Assets | |||||
| Total Assets | 15,511 | 20,005 | 20,775 | 23,128 | 23,975 |
| Accounts Payable | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 6,177 | 9,565 | 8,590 | 10,520 | 10,815 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Total Other Liabilities | |||||
| Total Funded Status | |||||
| Total Liabilities | 7,762 | 11,231 | 10,887 | 13,013 | 13,858 |
| Common Stock | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Total Equity | 7,750 | 8,775 | 9,887 | 10,115 | 10,117 |
| Total Liabilities & Shareholders' Equity | 15,511 | 20,005 | 20,775 | 23,128 | 23,975 |
| Total Common Shares Outstanding |